Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TESARO Inc (NASDAQ:TSRO)

149.11
Delayed Data
As of May 26
 -4.08 / -2.66%
Today’s Change
36.71
Today|||52-Week Range
192.94
+10.88%
Year-to-Date
Biotech Needs a Shot in the Arm
May 26 / TheStreet.com - Paid Partner Content
Clovis' (CLVS) PARP Inhibtor Shows Promise, Risks Remain
May 22 / Zacks.com - Paid Partner Content
Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna
May 23 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close153.19
Today’s open152.84
Day’s range148.58 - 156.22
Volume675,370
Average volume (3 months)975,784
Market cap$8.3B
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-27.43%
Earnings growth (this year)-5.85%
Earnings growth (next 5 years)+152.82%
Revenue growth (last year)+14,039.75%
P/E ratioNM
Price/Sales142.97
Price/Book13.44

Competitors

 Today’s
change
Today’s
% change
ALKSAlkermes Plc-0.24-0.41%
JAZZJazz Pharmaceuticals...-0.94-0.62%
SGENSeattle Genetics Inc-0.45-0.68%
RDYDr.Reddy's Laborator...-0.26-0.69%
Data as of 4:02pm ET, 05/26/2017

Financials

Next reporting dateJuly 27, 2017
EPS forecast (this quarter)-$2.58
Annual revenue (last year)$44.8M
Annual profit (last year)-$387.5M
Net profit margin-864.45%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Lonnie Moulder
President, Chief Operating Officer &
Director
Mary Lynne Hedley
Corporate headquarters
Waltham, Massachusetts

Forecasts